TME Pharma N.V.'s total assets for Q4 2025 were €2.14M, a decrease of -6.72% from the previous quarter. DE:0N6A total liabilities were €3.72M for the fiscal quarter, a 29.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.